A detailed history of Insight 2811, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Insight 2811, Inc. holds 5,202 shares of JNJ stock, worth $806,362. This represents 0.42% of its overall portfolio holdings.

Number of Shares
5,202
Previous 5,202 -0.0%
Holding current value
$806,362
Previous $760,000 10.92%
% of portfolio
0.42%
Previous 0.4%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$144.38 - $157.78 $28,876 - $31,556
-200 Reduced 3.7%
5,202 $760,000
Q1 2024

May 06, 2024

SELL
$155.22 - $162.74 $10,554 - $11,066
-68 Reduced 1.24%
5,402 $854,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $69,451 - $75,785
-477 Reduced 8.02%
5,470 $857,000
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $63,857 - $71,536
-410 Reduced 6.45%
5,947 $926,000
Q2 2023

Aug 04, 2023

BUY
$154.35 - $166.11 $5,093 - $5,481
33 Added 0.52%
6,357 $1.05 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $22,204 - $26,498
-147 Reduced 2.27%
6,324 $980,000
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $112,620 - $126,392
703 Added 12.19%
6,471 $1.14 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $73,243 - $81,502
454 Added 8.54%
5,768 $942,000
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $46,925 - $51,896
279 Added 5.54%
5,314 $943,000
Q1 2022

May 06, 2022

BUY
$158.14 - $179.59 $33,209 - $37,713
210 Added 4.35%
5,035 $892,000
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $53,483 - $59,342
343 Added 7.65%
4,825 $825,000
Q3 2021

Nov 04, 2021

SELL
$161.5 - $179.47 $46,512 - $51,687
-288 Reduced 6.04%
4,482 $724,000
Q2 2021

Aug 04, 2021

BUY
$159.48 - $171.07 $30,939 - $33,187
194 Added 4.24%
4,770 $786,000
Q1 2021

Apr 29, 2021

SELL
$153.07 - $170.48 $10,408 - $11,592
-68 Reduced 1.46%
4,576 $752,000
Q4 2020

Jan 29, 2021

SELL
$137.11 - $157.38 $85,556 - $98,205
-624 Reduced 11.85%
4,644 $731,000
Q3 2020

Oct 20, 2020

SELL
$140.38 - $153.83 $8,703 - $9,537
-62 Reduced 1.16%
5,268 $784,000
Q2 2020

Jul 21, 2020

SELL
$128.81 - $155.51 $112,837 - $136,226
-876 Reduced 14.12%
5,330 $788,000
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $132,812 - $184,018
-1,195 Reduced 16.15%
6,206 $814,000
Q4 2019

Feb 07, 2020

SELL
$127.5 - $146.44 $86,700 - $99,579
-680 Reduced 8.41%
7,401 $1.08 Million
Q3 2019

Oct 31, 2019

SELL
$126.95 - $142.14 $98,132 - $109,874
-773 Reduced 8.73%
8,081 $1.05 Million
Q2 2019

Jul 09, 2019

SELL
$131.15 - $144.24 $65,706 - $72,264
-501 Reduced 5.36%
8,854 $1.26 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $48,905 - $54,378
-389 Reduced 3.99%
9,355 $1.31 Million
Q4 2018

Feb 25, 2019

SELL
$122.84 - $147.84 $130,824 - $157,449
-1,065 Reduced 9.85%
9,744 $1.26 Million
Q3 2018

Nov 02, 2018

SELL
$121.58 - $142.88 $16,413 - $19,288
-135 Reduced 1.23%
10,809 $1.49 Million
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $100,415 - $110,810
-841 Reduced 7.14%
10,944 $1.33 Million
Q1 2018

May 03, 2018

BUY
$125.1 - $148.14 $137,610 - $162,953
1,100 Added 10.29%
11,785 $1.51 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $72,695 - $79,565
-554 Reduced 4.93%
10,685 $1.49 Million
Q3 2017

Oct 26, 2017

BUY
$129.47 - $135.38 $1.46 Million - $1.52 Million
11,239
11,239 $1.46 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Insight 2811, Inc. Portfolio

Follow Insight 2811, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight 2811, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Insight 2811, Inc. with notifications on news.